After Europe, UAE orders diabetes drug Avandia off shelves

DUBAI: The UAE's Health Ministry has ordered withdrawal of Avandia, a Type-2 diabetes drug, from all hospitals and pharmacies following a ban in Europe over fears that it could cause heart problems and strokes.

The ministry sent a circular in this regard to government and private hospitals and pharmacies in all medical zones, giving four weeks to ensure compliance.

Ameen Al Amiri, CEO for medical practice and licensing at the ministry, said the withdrawal of the drug follows directives from international health organisations.

The ministry's move came against the backdrop of a ban in Europe over fears that the drug could cause heart problems and strokes.

The UAE has a large number of people suffering from Type-2 diabetes.

Avandia contains a component called Rosiglitazone which is supposed to reduce sugar levels and improve insulin sensitivity.

In recent years, it has come under clouds after its efficacy was questioned amid warnings that it could lead to heart attacks in diabetic patients.